Atheer Labs

Atheer Labs secures $8.8M for its augmented reality glasses

The company has developed an augmented interactive reality platform AiR, which puts users in a gesture-controlled environment through special smart glasses.
PipelineRX

PipelineRX raises capital from California Healthcare Foundation

The fresh capital will help the company expand its services to more rural hospitals through a partnership with the California Hospital Association (CHA).
Transcriptic

Transcriptic secures $8.5M Series A for its robot-operated biolab

The Menlo Park-based company has raised just over $14 million to date for its robot-operated biolab, and is all set to move into drug-screening tests.
iGetBetter on iPad

iGetBetter closes $2.6M Series A investment round

The company will use the funds to complete the pilots it's currently running and convert them to commercial contracts, as well as for general operations.
TraceLink

TraceLink raises $20M to prevent counterfeit drug sales

The company will use the fresh capital to double its employee base (from 100 to 200) and move to expanded office space in North Reading.
Avizia

Telemedicine startup Avizia raises $4 million

The company will use the new money to speed up development, expand its workforce, introduce additional services and explore potential acquisitions.
Ebola gene

Scripps scores grant from USAID to fight Ebola

The mobile-enabled program will improve health outcomes for patients, increase the safety of health care workers and reduce the risk of spreading the virus.
Practo Android app

India’s Practo Technologies raises $30M for its doctor search service

The company plans to use the fresh funds to expand in nearly 30 Indian cities, South East Asia and the Middle East by March 2016.
ePatientFinder

ePatientFinder secures $2.58M Series A round

The funds will be used for the expansion of the provider and life-science networks, provider and patient engagement teams, and general corporate purposes.
Aventura

Aventura raises $14M Series C from Safeguard Scientifics and Merck GHIF

The company will use the money to expand sales and marketing, business development, and customer support, as well as accelerate product development.